Skip to main content
Top
Published in: Surgery Today 4/2018

01-04-2018 | Original Article

An analysis of the risk factors of anastomotic stricture after esophagectomy

Authors: Koji Tanaka, Tomoki Makino, Makoto Yamasaki, Takahiko Nishigaki, Yasuhiro Miyazaki, Tsuyoshi Takahashi, Yukinori Kurokawa, Kiyokazu Nakajima, Shuji Takiguchi, Masaki Mori, Yuichiro Doki

Published in: Surgery Today | Issue 4/2018

Login to get access

Abstract

Purpose

Anastomotic stricture after esophagectomy is a major cause of long-term morbidity and a poor quality of life. The aim of this study was to identify the risk factors for the development of anastomotic stricture after esophagectomy.

Methods

The study subjects were 213 patients who underwent esophagectomy for squamous cell carcinoma of the esophagus between 2012 and 2014. Anastomotic stricture was defined as stenosis at the site of anastomosis that required endoscopic dilation. Refractory stricture was defined as that requiring more than four sessions of dilations. Univariate and multivariate logistic regression analyses were used to identify the potential risk factors for the development of anastomotic stricture.

Results

In this retrospective study, 29 patients (13.6%) developed anastomotic stricture within a median period of 108 postoperative days and required a median of 2 dilations. Tumors located in the upper part of the esophagus (p = 0.004), the presence of cardiovascular disease (p = 0.024) and anastomotic leakage (p = 0.002) were identified as independent risk factors for the development of anastomotic stricture. The time to the diagnosis of refractory stricture (85 ± 33 days) was significantly shorter than that of non-refractory stricture (171 ± 22 days, p = 0.038).

Conclusions

Patients with squamous cell carcinoma in the upper esophagus with cardiovascular disease who develop postoperative anastomotic leakage should be carefully monitored to prevent the development of benign anastomotic stricture.
Literature
1.
go back to reference Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.CrossRefPubMed Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.CrossRefPubMed
2.
go back to reference Lew RJ, Kochman ML. A review of endoscopic methods of esophageal dilation. J Clin Gastroenterol. 2002;35:117 – 26.CrossRefPubMed Lew RJ, Kochman ML. A review of endoscopic methods of esophageal dilation. J Clin Gastroenterol. 2002;35:117 – 26.CrossRefPubMed
3.
go back to reference Heitmiller RF, Fischer A, Liddicoat JR. Cervical esophagogastric anastomosis: results following esophagectomy for carcinoma. Dis Esophagus. 1999;12:264–9.CrossRefPubMed Heitmiller RF, Fischer A, Liddicoat JR. Cervical esophagogastric anastomosis: results following esophagectomy for carcinoma. Dis Esophagus. 1999;12:264–9.CrossRefPubMed
4.
go back to reference Honkoop P, Siersema PD, Tilanus HW, Stassen LP, Hop WC, van Blankenstein M. Benign anastomotic strictures after transhiatal esophagectomy and cervical esophagogastrostomy: risk factors and management. J Thorac Cardiovasc Surg. 1996;111:1141–6 (discussion 7–8).CrossRefPubMed Honkoop P, Siersema PD, Tilanus HW, Stassen LP, Hop WC, van Blankenstein M. Benign anastomotic strictures after transhiatal esophagectomy and cervical esophagogastrostomy: risk factors and management. J Thorac Cardiovasc Surg. 1996;111:1141–6 (discussion 7–8).CrossRefPubMed
5.
go back to reference Martin L, Jia C, Rouvelas I, Lagergren P. Risk factors for malnutrition after oesophageal and cardia cancer surgery. Br J Surg. 2008;95:1362–8.CrossRefPubMed Martin L, Jia C, Rouvelas I, Lagergren P. Risk factors for malnutrition after oesophageal and cardia cancer surgery. Br J Surg. 2008;95:1362–8.CrossRefPubMed
6.
go back to reference Yamasaki M, Yasuda T, Yano M, Hirao M, Kobayashi K, Fujitani K, et al. Multicenter randomized phase II study of cisplatin and fluorouracil plus docetaxel (DCF) compared with cisplatin and fluorouracil plus adriamycin (ACF) as preoperative chemotherapy for resectable esophageal squamous cell carcinoma (OGSG1003). Ann Oncol. 2017;28:116–20.CrossRefPubMed Yamasaki M, Yasuda T, Yano M, Hirao M, Kobayashi K, Fujitani K, et al. Multicenter randomized phase II study of cisplatin and fluorouracil plus docetaxel (DCF) compared with cisplatin and fluorouracil plus adriamycin (ACF) as preoperative chemotherapy for resectable esophageal squamous cell carcinoma (OGSG1003). Ann Oncol. 2017;28:116–20.CrossRefPubMed
7.
go back to reference Yamashita K, Katada N, Moriya H, Hosoda K, Mieno H, Katada C, et al. Neoadjuvant chemotherapy of triplet regimens of docetaxel/cisplatin/5-FU (DCF NAC) may improve patient prognosis of cStage II/III esophageal squamous cell carcinoma-propensity score analysis. Gen Thorac Cardiovasc Surg. 2016;64:209–15.CrossRefPubMed Yamashita K, Katada N, Moriya H, Hosoda K, Mieno H, Katada C, et al. Neoadjuvant chemotherapy of triplet regimens of docetaxel/cisplatin/5-FU (DCF NAC) may improve patient prognosis of cStage II/III esophageal squamous cell carcinoma-propensity score analysis. Gen Thorac Cardiovasc Surg. 2016;64:209–15.CrossRefPubMed
8.
go back to reference Cuesta MA, van der Wielen N, Straatman J, van der Peet DL. Video-assisted thoracoscopic esophagectomy: keynote lecture. Gen Thorac Cardiovasc Surg. 2016;64:380–5.CrossRefPubMedPubMedCentral Cuesta MA, van der Wielen N, Straatman J, van der Peet DL. Video-assisted thoracoscopic esophagectomy: keynote lecture. Gen Thorac Cardiovasc Surg. 2016;64:380–5.CrossRefPubMedPubMedCentral
9.
go back to reference Wada H, Doki Y, Nishioka K, Ishikawa O, Kabuto T, Yano M, et al. Clinical outcome of esophageal cancer patients with history of gastrectomy. J Surg Oncol. 2005;89:67–74.CrossRefPubMed Wada H, Doki Y, Nishioka K, Ishikawa O, Kabuto T, Yano M, et al. Clinical outcome of esophageal cancer patients with history of gastrectomy. J Surg Oncol. 2005;89:67–74.CrossRefPubMed
10.
go back to reference Watanabe M, Mine S, Nishida K, Kurogochi T, Okamura A, Imamura Y. Reconstruction after esophagectomy for esophageal cancer patients with a history of gastrectomy. Gen Thorac Cardiovasc Surg. 2016;64:457–63.CrossRefPubMed Watanabe M, Mine S, Nishida K, Kurogochi T, Okamura A, Imamura Y. Reconstruction after esophagectomy for esophageal cancer patients with a history of gastrectomy. Gen Thorac Cardiovasc Surg. 2016;64:457–63.CrossRefPubMed
11.
12.
go back to reference Yoda Y, Yano T, Kaneko K, Tsuruta S, Oono Y, Kojima T, et al. Endoscopic balloon dilatation for benign fibrotic strictures after curative nonsurgical treatment for esophageal cancer. Surg Endosc. 2012;26:2877–83.CrossRefPubMed Yoda Y, Yano T, Kaneko K, Tsuruta S, Oono Y, Kojima T, et al. Endoscopic balloon dilatation for benign fibrotic strictures after curative nonsurgical treatment for esophageal cancer. Surg Endosc. 2012;26:2877–83.CrossRefPubMed
13.
go back to reference Sutcliffe RP, Forshaw MJ, Tandon R, Rohatgi A, Strauss DC, Botha AJ, et al. Anastomotic strictures and delayed gastric emptying after esophagectomy: incidence, risk factors and management. Dis Esophagus. 2008;21:712–7.CrossRefPubMed Sutcliffe RP, Forshaw MJ, Tandon R, Rohatgi A, Strauss DC, Botha AJ, et al. Anastomotic strictures and delayed gastric emptying after esophagectomy: incidence, risk factors and management. Dis Esophagus. 2008;21:712–7.CrossRefPubMed
14.
go back to reference Pierie JP, de Graaf PW, Poen H, van der Tweel I, Obertop H. Incidence and management of benign anastomotic stricture after cervical oesophagogastrostomy. Br J Surg. 1993;80:471–4.CrossRefPubMed Pierie JP, de Graaf PW, Poen H, van der Tweel I, Obertop H. Incidence and management of benign anastomotic stricture after cervical oesophagogastrostomy. Br J Surg. 1993;80:471–4.CrossRefPubMed
15.
go back to reference van Heijl M, Gooszen JA, Fockens P, Busch OR, van Lanschot JJ, van Berge Henegouwen MI. Risk factors for development of benign cervical strictures after esophagectomy. Ann Surg. 2010;251:1064–9.CrossRefPubMed van Heijl M, Gooszen JA, Fockens P, Busch OR, van Lanschot JJ, van Berge Henegouwen MI. Risk factors for development of benign cervical strictures after esophagectomy. Ann Surg. 2010;251:1064–9.CrossRefPubMed
16.
go back to reference Ahmed Z, Elliott JA, King S, Donohoe CL, Ravi N, Reynolds JV. Risk factors for anastomotic stricture post-esophagectomy with a standardized sutured anastomosis. World J Surg. 2017;41:487–97.CrossRefPubMed Ahmed Z, Elliott JA, King S, Donohoe CL, Ravi N, Reynolds JV. Risk factors for anastomotic stricture post-esophagectomy with a standardized sutured anastomosis. World J Surg. 2017;41:487–97.CrossRefPubMed
17.
go back to reference Johansson J, Oberg S, Wenner J, Zilling T, Johnsson F, von Holstein CS, et al. Impact of proton pump inhibitors on benign anastomotic stricture formations after esophagectomy and gastric tube reconstruction: results from a randomized clinical trial. Ann Surg 2009;250:667–73.CrossRefPubMed Johansson J, Oberg S, Wenner J, Zilling T, Johnsson F, von Holstein CS, et al. Impact of proton pump inhibitors on benign anastomotic stricture formations after esophagectomy and gastric tube reconstruction: results from a randomized clinical trial. Ann Surg 2009;250:667–73.CrossRefPubMed
18.
go back to reference Petrin G, Ruol A, Battaglia G, Buin F, Merigliano S, Constantini M, et al. Anastomotic stenoses occurring after circular stapling in esophageal cancer surgery. Surg Endosc. 2000;14:670–4.CrossRefPubMed Petrin G, Ruol A, Battaglia G, Buin F, Merigliano S, Constantini M, et al. Anastomotic stenoses occurring after circular stapling in esophageal cancer surgery. Surg Endosc. 2000;14:670–4.CrossRefPubMed
19.
go back to reference Chung RS, Hitch DC, Armstrong DN. The role of tissue ischemia in the pathogenesis of anastomotic stricture. Surgery. 1988;104:824–9.PubMed Chung RS, Hitch DC, Armstrong DN. The role of tissue ischemia in the pathogenesis of anastomotic stricture. Surgery. 1988;104:824–9.PubMed
20.
go back to reference Salo JA, Perhoniemi VJ, Heikkinen LO, Verkkala KA, Jarvinen AA. Pulse oximetry for the assessment of gastric tube circulation in esophageal replacements. Am J Surg. 1992;163:446–7.CrossRefPubMed Salo JA, Perhoniemi VJ, Heikkinen LO, Verkkala KA, Jarvinen AA. Pulse oximetry for the assessment of gastric tube circulation in esophageal replacements. Am J Surg. 1992;163:446–7.CrossRefPubMed
21.
go back to reference Pierie JP, De Graaf PW, Poen H, Van der Tweel I, Obertop H. Impaired healing of cervical oesophagogastrostomies can be predicted by estimation of gastric serosal blood perfusion by laser Doppler flowmetry. Eur J Surg. 1994;160:599–603.PubMed Pierie JP, De Graaf PW, Poen H, Van der Tweel I, Obertop H. Impaired healing of cervical oesophagogastrostomies can be predicted by estimation of gastric serosal blood perfusion by laser Doppler flowmetry. Eur J Surg. 1994;160:599–603.PubMed
Metadata
Title
An analysis of the risk factors of anastomotic stricture after esophagectomy
Authors
Koji Tanaka
Tomoki Makino
Makoto Yamasaki
Takahiko Nishigaki
Yasuhiro Miyazaki
Tsuyoshi Takahashi
Yukinori Kurokawa
Kiyokazu Nakajima
Shuji Takiguchi
Masaki Mori
Yuichiro Doki
Publication date
01-04-2018
Publisher
Springer Singapore
Published in
Surgery Today / Issue 4/2018
Print ISSN: 0941-1291
Electronic ISSN: 1436-2813
DOI
https://doi.org/10.1007/s00595-017-1608-5

Other articles of this Issue 4/2018

Surgery Today 4/2018 Go to the issue